[Federal Register: March 16, 1999 (Volume 64, Number 50)]
[Notices]               
[Page 13029]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16mr99-72]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 93N-0445]

 
Agency Information Collection Activities; Announcement of OMB 
Approval; Financial Disclosure by Clinical Investigators

AGENCY: Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Financial Disclosure by Clinical 
Investigators'' has been approved by the Office of Management and 
Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:  JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION:  In the Federal Register of December 31, 
1998 (63 FR 72171), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0396. 
The approval expires on March 31, 2002. A copy of the supporting 
statement for this information collection is available on the Internet 
at ``http://www.fda.gov/ohrms/dockets''.

    Dated: March 9, 1999.
 William K. Hubbard,
 Acting Deputy Commissioner for Policy.
[FR Doc. 99-6339 Filed 3-15-99; 8:45 am]
BILLING CODE 4160-01-F